Healthcare Aug 17, 2020 03:54 PM (GMT+8) · EqualOcean
Galixier, an AI-embedded research solution provider for developing new drugs, announced to close the pre-Series A fundraising of close to USD 10 million. Source Code Capital and DCM Ventures led the investment, participated by Banyan VC and Morningside VC. The bankroll will assist the development of the technology platform and the expansion of the research team. The performance of Schrödinger (SDGR:Nasdaq) on Nasdaq indicated investors' confidence in the new medicine R & D platform. Considering the tremendous demand for new drugs in the Chinese market, the combination of AI technology and new drug research can accelerate the research process and improve commercialization.

This text is a result of machine translation.